Springfield, VA, United States of America

Mark Cosentino



Average Co-Inventor Count = 6.4

ph-index = 3

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 1997-2001

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Mark Cosentino: Innovator in Pharmaceutical Chemistry

Introduction

Mark Cosentino is a notable inventor based in Springfield, VA (US), recognized for his contributions to pharmaceutical chemistry. With a total of 4 patents, he has made significant strides in the development of compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents is the invention titled "Suksdorfin analogs, compositions thereof, and methods for making and using thereof." This invention focuses on compounds that are analogs of the natural product suksdorfin. The compounds include those represented by a specific formula, which are designed to treat retroviral infections. Additionally, the patent describes a stereoselective method for synthesizing these compounds, showcasing his innovative approach to pharmaceutical development.

Career Highlights

Mark Cosentino has worked with esteemed institutions such as the University of North Carolina at Chapel Hill and Biotech Research Laboratories. His work in these organizations has allowed him to advance his research and contribute to the field of biotechnology.

Collaborations

Throughout his career, Mark has collaborated with notable professionals, including Kuo-Hsiung Lee and Lan Xie. These collaborations have enriched his research and expanded the impact of his inventions.

Conclusion

Mark Cosentino's work in developing pharmaceutical compounds demonstrates his commitment to innovation in the field of chemistry. His patents and collaborations reflect a dedication to advancing medical science and improving treatment options for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…